2017 ESC REPORT : European Society of Cardiology (ESC) Annual Congress Report From Barcelona 2017
-
- Satoh Kimio
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Takahashi Jun
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Matsumoto Yasuharu
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Tatebe Shunsuke
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Aoki Tatsuo
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Kikuchi Yoku
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Hao Kiyotaka
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Ohyama Kazuma
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Nogi Masamichi
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Suda Akira
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Kasahara Shintaro
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Sato Koichi
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Ichijo Sadamitsu
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
-
- Shimokawa Hiroaki
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
書誌事項
- タイトル別名
-
- European Society of Cardiology (ESC) Annual Congress Report From Barcelona 2017
この論文をさがす
説明
<p>From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.</p>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 81 (12), 1758-1763, 2017
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680084090240
-
- NII論文ID
- 130006219237
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 028673695
-
- PubMed
- 29093432
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可
